{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:41:29Z","timestamp":1786714889467,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Sex Transm Dis"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/0253-7184.203438","type":"journal-article","created":{"date-parts":[[2017,3,30]],"date-time":"2017-03-30T04:34:14Z","timestamp":1490848454000},"page":"60","source":"Crossref","is-referenced-by-count":3,"title":["Proton pump inhibitors are associated with a reduced likelihood for sexually transmitted diseases in women in the emergency department"],"prefix":"10.4103","volume":"38","author":[{"given":"JohnathanMichael","family":"Sheele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Byars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Counselman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0253-7184.203438-1","first-page":"43","volume-title":"Trichomonas vaginalis vaginitis in obstetrics and gynecology practice: New concepts and controversies","author":"Coleman","year":"2013","journal-title":"Obstet Gynecol Surv"},{"key":"key-10.4103\/0253-7184.203438-2","first-page":"359","volume-title":"Glycogen accumulation and degradation by the trichomonads Trichomonas vaginalis and Trichomonas tenax","author":"Nielsen","year":"2012","journal-title":"J Eukaryot Microbiol"},{"key":"key-10.4103\/0253-7184.203438-3","first-page":"58","volume-title":"Sexually transmitted diseases treatment guidelines","author":"Centers","year":"2010","journal-title":"Morb Mortal Wkly Rep"},{"key":"key-10.4103\/0253-7184.203438-4","first-page":"6","volume-title":"Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000","author":"Weinstock","year":"2004","journal-title":"Perspect Sex Reprod Health"},{"key":"key-10.4103\/0253-7184.203438-5","first-page":"783","volume-title":"Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis","author":"Cudmore","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"key-10.4103\/0253-7184.203438-6","first-page":"794","volume-title":"Trichomoniasis","author":"Schwebke","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"key-10.4103\/0253-7184.203438-7","unstructured":"Neglected Parasitic Infections in the United States; 2012. Available from: http:\/\/www.cdc.gov\/parasites\/npi.html. [Last accessed on 2012 Aug 15]."},{"key":"key-10.4103\/0253-7184.203438-8","first-page":"267","volume-title":"Trichomonas vaginalis weakens human amniochorion in an in vitro model of premature membrane rupture","author":"Draper","year":"1995","journal-title":"Infect Dis Obstet Gynecol"},{"key":"key-10.4103\/0253-7184.203438-9","first-page":"935","volume-title":"Proton pump inhibitors: An update of their clinical use and pharmacokinetics","author":"Shi","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"key-10.4103\/0253-7184.203438-10","unstructured":"The Human Protein Atlas. Available from: http:\/\/www.proteinatlas.org\/ENSG00000186009\/normal. [Last accessed on 2015 Jul 20]."},{"key":"key-10.4103\/0253-7184.203438-11","unstructured":"The Human Protein Atlas. Available from: http:\/\/www.proteinatlas.org\/ENSG00000105675\/normal. [Last accessed on 2015 Jul 20]."},{"key":"key-10.4103\/0253-7184.203438-12","first-page":"7351","volume-title":"Antiprotozoal activity of proton-pump inhibitors","author":"P\u00e9rez-Villanueva","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"key-10.4103\/0253-7184.203438-13","first-page":"144","volume-title":"In vitro susceptibility of Trichomonas vaginalis to 50 antimicrobial agents","author":"Sears","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0253-7184.203438-14","first-page":"221","volume-title":"In-vitro susceptibility of Giardia lamblia to albendazole, mebendazole and other chemotherapeutic agents","author":"Cedillo-Rivera","year":"1992","journal-title":"J Med Microbiol"},{"key":"key-10.4103\/0253-7184.203438-15","first-page":"510","volume-title":"Giardia lamblia: Ultrastructural study of the in vitro effect of benzimidazoles","author":"Chavez","year":"1992","journal-title":"J Protozool"},{"key":"key-10.4103\/0253-7184.203438-16","first-page":"1080","volume-title":", Parkin DW, et al. Identification of proton-pump inhibitor drugs that inhibit Trichomonas vaginalis uridine nucleoside ribohydrolase","author":"Shea","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"key-10.4103\/0253-7184.203438-17","first-page":"2185","volume-title":"Pyruvate decarboxylase, the target for omeprazole in metronidazole-resistant and iron-restricted Tritrichomonas foetus","author":"Sutak","year":"2004","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Indian Journal of Sexually Transmitted Diseases and AIDS"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:22:40Z","timestamp":1786713760000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0253-7184.203438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"alternative-id":["203438"],"URL":"https:\/\/doi.org\/10.4103\/0253-7184.203438","relation":{},"ISSN":["2589-0557"],"issn-type":[{"value":"2589-0557","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}